⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8749639 | 1.00 | — | — | |
| SCHEMBL8749610 | 1.00 | — | — | |
| SCHEMBL10092854 | 0.73 | — | — | |
| SCHEMBL12524747 | 0.73 | — | — | |
| SCHEMBL8999504 | 0.73 | — | — | |
| SCHEMBL3149033 | 0.73 | — | — | |
| SCHEMBL21670204 | 0.72 | — | — | |
| SCHEMBL9031381 | 0.71 | — | — | |
| SCHEMBL7875972 | 0.71 | — | — | |
| SCHEMBL7877822 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5516806-A | ANTITUMOR | CIBA-GEIGY CORPORATION (US) | 1996-05-14 | — | — | US | disclosed |